Go to:
Logótipo
You are in:: Start > Publications > View > rhEPO for the Treatment of Erythropoietin Resistant Anemia in Hemodialysis Patients – Risks and Benefits
Map of Premises
FC6 - Departamento de Ciência de Computadores FC5 - Edifício Central FC4 - Departamento de Biologia FC3 - Departamento de Física e Astronomia e Departamento GAOT FC2 - Departamento de Química e Bioquímica FC1 - Departamento de Matemática
Publication

rhEPO for the Treatment of Erythropoietin Resistant Anemia in Hemodialysis Patients – Risks and Benefits

Title
rhEPO for the Treatment of Erythropoietin Resistant Anemia in Hemodialysis Patients – Risks and Benefits
Type
Chapter or Part of a Book
Year
2013
Authors
Sandra Ribeiro
(Author)
FFUP
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Elisio Costa
(Author)
FFUP
View Personal Page You do not have permissions to view the institutional email. Search for Participant Publications View Authenticus page View ORCID page
Luís Belo
(Author)
FFUP
View Personal Page You do not have permissions to view the institutional email. Search for Participant Publications View Authenticus page Without ORCID
Flávio Reis
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Alice Santos Silva
(Author)
FEUP
View Personal Page You do not have permissions to view the institutional email. Search for Participant Publications View Authenticus page View ORCID page
Scientific classification
FOS: Medical and Health sciences
Other information
Language: Portuguese
Type (Professor's evaluation): Scientific
Documents
We could not find any documents associated to the publication.
Recommend this page Top
Copyright 1996-2025 © Faculdade de Ciências da Universidade do Porto  I Terms and Conditions  I Acessibility  I Index A-Z  I Guest Book
Page created on: 2025-06-29 at 17:37:40 | Acceptable Use Policy | Data Protection Policy | Complaint Portal